Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 29NIH 3NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 13Neuroblastoma 10Leukemia 9Central Nervous System Neoplasms 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Brain Neoplasms 8Hodgkin Disease 5Burkitt Lymphoma 5Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Large B-Cell, Diffuse 4Dendritic Cell Sarcoma, Interdigitating 4Medulloblastoma 3Leukemia, Biphenotypic, Acute 3Astrocytoma 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Osteosarcoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Malignant mesenchymal tumor 2Leukemia, Myeloid, Acute 2Leukemia, Monocytic, Acute 2Kidney Neoplasms 2Cardiotoxicity 2Carcinoma, Renal Cell 2

Interventions

Rituximab 8Vincristine 5Doxorubicin 5Cyclophosphamide 5Methotrexate 4Cytarabine 4Bortezomib 4Radiotherapy 3Prednisone 3Bendamustine Hydrochloride 3Peripheral Blood Stem Cell Transplantation 2Melphalan 2Leucovorin 2Dexamethasone 2CT-P10 2zanubrutinib 1obinutuzumab 1merphos 1liposomal amphotericin B 1ixabepilone 1ibritumomab tiuxetan 1fludarabine phosphate 1carmustine, poliferprosan 20 drug combination 1alvocidib 1acalabrutinib 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Tazobactam 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Mantle-Cell × Granulocyte Colony-Stimulating Factor × Clear all
NCT00041132 2012-11-01

S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
56 enrolled 9 charts
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡